NIH-funded research R01 grant

How short-term cannabis use and withdrawal affect teen mood and suicidal thoughts

Official title: Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation with Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment

Funded at Massachusetts General Hospital · NIH-11323622 · Data updated 2026-11-12

Teens who use cannabis daily and have recent depression or suicidal thoughts will use a smartphone app that records their mood and cannabis use to link moments of use or withdrawal with increases in sadness or suicidal thinking.

More Cannabis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$763,679
NIH project number5R01DA054145-03
Project IDNIH-11323622 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are school-age adolescents (about 12–18 years) who use cannabis daily or nearly daily, have current depression, and have had suicidal thoughts within the past month.

Less likely to help

Young people who do not use cannabis regularly, do not have current depression or recent suicidal thoughts, are outside the 12–18 age range, or are unable or unwilling to complete frequent smartphone monitoring are unlikely to benefit directly from this study.

What this research studies

If you join, you'll be 12–18 years old, use cannabis daily or nearly daily, have current depression, and have had suicidal thoughts in the past month, and you may be recruited through your school. Over a 10-week study you'll carry a smartphone app that prompts you multiple times per day to report your mood, suicidal thoughts, and cannabis use, including an initial 2-week baseline period during your usual use. The study uses random assignment to compare conditions such as sustained abstinence versus continued use and follows participants through intoxication and withdrawal to identify when mood or suicidal thinking worsens. Study staff will monitor safety, provide instructions, and connect participants with care if needed.

Why it matters

Potential benefit: If successful, this work could identify specific high-risk moments during intoxication or withdrawal when teens are most likely to experience worsening depression or suicidal thoughts, allowing earlier and more targeted interventions.

How similar studies have gone: Previous research has linked adolescent cannabis use with depression and suicidal thoughts over months and years, but real-time, short-term smartphone monitoring in this high-risk group is relatively new and less tested.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Schuster, Randi Melissa — Massachusetts General Hospital
  • Study coordinator: Schuster, Randi Melissa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.